News Highlights: Top Company News of the Day
January 25 2022 - 1:30PM
Dow Jones News
GE's Sales Decline 3%, Hit by Supply-Chain Woes
The conglomerate projected a return to sales growth this year as
its aviation business begins to recover.
American Express Boosts Forecasts as Credit Card Spending Sets Record
For the full year, American Express expects to generate revenue
growth in the range of 18% to 20% and earnings per share of $9.25
to $9.65.
Elon Musk Urges McDonald's to Accept Dogecoin for Payment
The Tesla CEO tweeted that he would eat a Happy Meal on TV if
the fast-food giant began accepting the cryptocurrency.
FTC Sues to Block Lockheed Martin Acquisition of Aerojet Rocketdyne
The Federal Trade Commission says the proposed $4.4 billion
purchase would allow the defense giant to control access to parts
needed to build missile engines.
Casino Operator Bally's Shares Jump on Standard General Buyout Offer
The stock soars more than 20% after Standard General offers to
buy the shares it doesn't already own in a deal that values the
company at $2.07 billion.
Kroger Workers Approve New Contract After Nine-Day Strike
More than 8,000 unionized workers ratify a contract that gives
them wage increases and better healthcare and pension benefits.
AMC in Advanced Talks to Refinance Debt as Meme-Stock Luster Fades
Shares and bonds of AMC Entertainment have sunk this year,
reversing most of their gains since the cinema chain became a
meme-stock favorite and coming as the company steps up efforts to
ink a refinancing deal.
Nvidia stock falls after report says company could give up on Arm deal
Shares of Nvidia Corp. were declining in Tuesday trading after a
report indicated that the company is preparing to give up on its
planned purchase of Arm Ltd. from SoftBank Group Corp.
GM Pumps More Money Into EVs, Picks Michigan for Big Investment
The Detroit auto maker doubles down on electric-truck production
and plans an battery-cell factory with LG Energy Solution, creating
4,000 new jobs in the Great Lakes state.
Johnson & Johnson Posts Higher Quarterly Sales Despite Some Pandemic-Related Pains
The health company finished 2021 with its strongest quarter to
date for Covid-19 vaccine sales, contributing to year-over-year
revenue growth across its operations as it prepares to separate its
consumer-health division.
(END) Dow Jones Newswires
January 25, 2022 13:15 ET (18:15 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.